Medications not yet evaluated by P&T are considered NON-FORMULARY . . . . . Always check 2 unique patient identifiers - NAME and DATE OF BIRTH - at every step! . . . . . Please be sure to document all clinical activities daily.
Search results for:

gefitinib

gefitinib
Drug Name Form Strength Formulary Unrestricted Formulary Restricted Non-Formulary Interchange
Iressa TABLET, ORAL 250 mg      


Comments:

At Huntsville Main/W&C/Madison, orders for this medication should be rejected and reviewed by an oncology clinical specialist or an oncology pool member (see second page of the document "Hormone Therapies and Guidance on Oral Chemotherapy") 

 

Non-formulary, not stocked. Drug is restricted to use mainly in clinical trials. If rare non-study patient is on the drug, the patient should use home supply.


Last updated: Aug. 12, 2025







This site is intended for the staff of Huntsville Hospital.
While others may view accessible pages, Huntsville Hospital makes no warranty, express or implied,
as to the use of this information outside of Huntsville Hospital.
Please note than many documents are accessible via the provided link
only when connected to the Huntsville Hospital intranet.